MarginsXMarginsX
Home › Markets › Health Care › FLGT

Fulgent Genetics Inc. (FLGT)

FLGT trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$24.07
-2.37% on the day
Market cap
$672.6M
Small cap
Revenue · 2025
$322.7M
+13.8% on 2024
Net income · 2025
-$60.5M
-18.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1674930/000119312526079169/0001193125-26-079169-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerFLGT on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2016
SEC CIK0001674930
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials · 2025

LineValue
Revenue$322.7M
Net income-$60.5M
Operating income-$91.1M
Net margin-18.8%
Operating margin-28.2%
Revenue growth+13.8%
Cash$50.2M
Total assets$1.2B
P/E (computed)Net income was not positive
P/S (computed)2.1×

Warning signs

Cash runway
Cash-flow positive
$86.8M cash at September 30, 2026
Share count, 1 year
-9.6%
2025-11-03 to 2026-11-02 · -5.7% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$678K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$86.8M cash; operating cash flow $3.6M a quarter.Report 2026-09-30
Shares outstanding27,939,000 (2026-11-02); 30,912,392 a year earlier; 29,633,057 three years earlier.Cover page 2026-11-02
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Los Angeles, California, United StatesPCAOB Form AP 2026-03-10
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $678K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$90.4M-$13.2M$109.2M$86.8M$482K$330.3M10-Q 2026-11-05
Q2 2026
2026-06-30
$85.4M-$29.5M-$23.8M$26.3M$482K$323.9M10-Q 2026-07-30
Q1 2026
2026-03-31
$71.1M-$24.8M$7.1M$23.4M$482K$320.3M10-Q 2026-05-01
Q4 2025
2025-12-31
$83.3M-$23.4M-$78.1M$50.2M$476K$322.7M10-K 2026-02-27
Q3 2025
2025-09-30
$84.1M-$6.6M$11.1M$117.6M$476K$315.5M10-Q 2026-11-05
Q2 2025
2025-06-30
$81.8M-$19.0M-$30.2M$87.9M$476K$303.2M10-Q 2026-07-30
Q1 2025
2025-03-31
$73.5M-$11.5M-$4.4M$67.3M$476K$292.4M10-Q 2026-05-01
Q4 2024
2024-12-31
$76.2M-$5.9M$25.0M$55.1M$412K$283.5M10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52020-11-20
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-03-31

Source: SEC EDGAR submissions feed, 670 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.9%
1 month+17.1%
3 months+32.2%
Year to date-6.1%
1 year-16.7%
From 52-week high-20.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
CSTLCastle Biosciences Inc.$32.75-3.08%$1.0B
FRNMFreenome Inc.$10.09-3.07%$1.1B
YDESYD Bio Limited$4.83-1.02%$342.1M
LMRILumexa Imaging Holdings Inc.$14.79-0.14%$1.4B
ALHCAlignment Healthcare Inc.$7.47+1.49%$1.6B
TRUPTrupanion Inc.$36.16+4.87%$1.6B
PSNLPersonalis Inc.$14.80-5.79%$1.6B
FTREFortrea Holdings Inc.$19.79-2.03%$1.9B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier